)
AtriCure (ATRC) investor relations material
AtriCure The Citizens Life Sciences Conference 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Growth outlook and guidance for 2026
Organic growth expected at 12%-14% for 2026, slightly higher than 2025 guidance, driven by strong product launches and expanding adoption in core areas.
Pain management franchise, with recent product launches, is projected to outpace other segments, especially in the underpenetrated thoracic market.
New device launch for pain management in amputation procedures offers additional upside as the market matures.
Open heart surgery segment benefits from steady adoption of the EnCompass clamp and new AtriClip products, with growth in line with overall company guidance.
Standalone Afib treatment (hybrid business) remains a headwind but is expected to decline less in 2026 compared to 2025.
Product innovation and adoption trends
EnCompass clamp reduced procedure time from 30-45 minutes to 8-10 minutes, driving increased adoption, especially among CABG surgeons, with U.S. penetration rising to about 20% by end of 2025.
Pain management devices like cryoSPHERE+ and cryoSPHERE MAX have accelerated adoption by significantly reducing procedure times, with minimal barriers to adoption despite reimbursement challenges.
New cryoXT device targets post-amputation pain, addressing a growing market of 180,000 annual U.S. amputations, with strong initial feedback and a dedicated device design.
AtriClip FLEX-Mini, launched in 2024, exceeded expectations with volume-driven growth and ASP uplift, driven by demand for smaller devices.
AtriClip PRO-Mini enables minimally invasive procedures, but growth is limited by underlying procedure volume despite ASP improvements.
Competitive landscape and market dynamics
Entry of new competitors in appendage management is seen as validation of market opportunity, with innovation and clinical science as key differentiators.
Competition is expected to raise awareness and expand the market, with three major cardiac companies now active in appendage management.
In pain management, cryoanalgesia is not new, but significant capital investment and differentiated technology are barriers for new entrants.
Next AtriCure earnings date
Next AtriCure earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)